Rezultati - Cavazos, David

Modulation of Telomeres in Alternative Lengthening of Telomeres Type I Like Human Cells by the Expression of Werner Protein and Telomerase od Siddiqa, Aisha, Cavazos, David, Chavez, Jeffery, Long, Linda, Marciniak, Robert A.

Polni tekst Polni tekst Polni tekst

METB-09. METABOLIC ADAPTATION TO CHRONIC HYPOXIA IN GLIOBLASTOMA CELLS od Caflisch, Laura, Lodi, Alessia, Gruslova, Aleksandra, Cavazos, David, Garcia, Michael, Tiziani, Stefano, Brenner, Andrew

Polni tekst Polni tekst

miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer od Yu, Xiaojie, Zhang, Yiqiang, Cavazos, David, Ma, Xiuye, Zhao, Zhenze, Du, Liqin, Pertsemlidis, Alexander

Polni tekst Polni tekst Polni tekst

Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression od Bowers, Laura W, Cavazos, David A, Maximo, Ilane XF, Brenner, Andrew J, Hursting, Stephen D, deGraffenried, Linda A

Polni tekst Polni tekst Polni tekst

Obesity Promotes Aerobic Glycolysis in Prostate Cancer Cells od Cavazos, David A., deGraffenried, Matthew J., Apte, Shruti A., Bowers, Laura W., Whelan, Kaitlin A., deGraffenried, Linda A.

Polni tekst Polni tekst Polni tekst

MNGI-11. TREATMENT OF MENINGIOMA WITH TH-302 IN A PDX MOUSE MODEL AND CELL LINE od Patel, Vaibhav, Maknojia, Asif, Garcia, Michael, Cavazos, David, Gruslova, Aleksandra, Courtney, Bosse, Papanikolaou, Niko, Kidane, Dawit, Brenner, Andrew, Floyd, John

Polni tekst Polni tekst

DD-02 PHARMACODYNAMIC BIOMARKER ASSESSMENTS IN A PHASE I/II TRIAL OF THE HYPOXIA-ACTIVATED PRODRUG TH-302 AND BEVACIZUMAB IN BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA od Cavazos, David, Gruslova, Aleksandra, Sun, J., Floyd, John R., Fichtel, Lisa, Tadi, Surendar, Lodi, Alessia, Tiziani, Stefano, Hart, C.P., Eng, Clarence, Brenner, Andrew

Polni tekst Polni tekst

VB-111: A novel anti-vascular therapeutic for glioblastoma multiforme od Gruslova, Aleksandra, Cavazos, David A, Miller, Jessica R., Breitbart, Eyal, Cohen, Yael C, Bangio, Livnat, Yakov, Niva, Soundararajan, Anu, Floyd, John R., Brenner, Andrew J.

Polni tekst Polni tekst Polni tekst

Hypoxia-activated evofosfamide for treatment of recurrent bevacizumab-refractory glioblastoma: a phase I surgical study od Brenner, Andrew, Zuniga, Richard, Sun, Jessica D, Floyd, John, Hart, Charles P, Kroll, Stew, Fichtel, Lisa, Cavazos, David, Caflisch, Laura, Gruslova, Aleksandra, Huang, Shiliang, Liu, Yichu, Lodi, Alessia, Tiziani, Stefano

Polni tekst Polni tekst Polni tekst

Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma od Sareddy, Gangadhara R., Li, Xiaonan, Liu, Jinyou, Viswanadhapalli, Suryavathi, Garcia, Lauren, Gruslova, Aleksandra, Cavazos, David, Garcia, Mike, Strom, Anders M., Gustafsson, Jan-Ake, Tekmal, Rajeshwar Rao, Brenner, Andrew, Vadlamudi, Ratna K.

Polni tekst Polni tekst Polni tekst

5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells() od Henry, Sean, Kidner, Ria, Reisenauer, Mary R., Magedov, Igor V., Kiss, Robert, Mathieu, Véronique, Lefranc, Florence, Dasari, Ramesh, Evidente, Antonio, Yu, Xiaojie, Ma, Xiuye, Pertsemlidis, Alexander, Cencic, Regina, Pelletier, Jerry, Cavazos, David A., Brenner, Andrew J., Aksenov, Alexander V., Rogelj, Snezna, Kornienko, Alexander, Frolova, Liliya V.

Polni tekst Polni tekst Polni tekst

Activity of 2-Aryl-2-(3-indolyl)acetohydroxamates Against Drug-Resistant Cancer Cells od Aksenov, Alexander V., Smirnov, Alexander N., Magedov, Igor V., Reisenauer, Mary R., Aksenov, Nicolai A., Aksenova, Inna V., Pendleton, Alexander L., Nguyen, Gina, Johnston, Robert K., Rubin, Michael, De Carvalho, Annelise, Kiss, Robert, Mathieu, Véronique, Lefranc, Florence, Correa, Jaime, Cavazos, David A., Brenner, Andrew J., Bryan, Brad A., Rogelj, Snezna, Kornienko, Alexander, Frolova, Liliya V.

Polni tekst Polni tekst Polni tekst